Dr. Katrina Wade, MD
Claim this profileOchsner Medical Center Jefferson
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
10 reported clinical trials
24 drugs studied
Area of expertise
1Ovarian Cancer
FRα positive
HRAS positive
KRAS positive
2Fallopian Tube Cancer
FRα positive
HRAS positive
KRAS positive
Affiliated Hospitals
Clinical Trials Katrina Wade, MD is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Selumetinib + Olaparib
for Ovarian and Endometrial Cancer
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.
Recruiting1 award Phase 2
More about Katrina Wade, MD
Clinical Trial Related5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Katrina Wade, MD has experience with
- Paclitaxel
- Mirvetuximab Soravtansine
- Carboplatin
- Bevacizumab
- Olaparib
- Topotecan
Breakdown of trials Katrina Wade, MD has run
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Neoplasm
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katrina Wade, MD specialize in?
Katrina Wade, MD focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved FRα positive patients, or patients who are HRAS positive.
Is Katrina Wade, MD currently recruiting for clinical trials?
Yes, Katrina Wade, MD is currently recruiting for 2 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Katrina Wade, MD has studied deeply?
Yes, Katrina Wade, MD has studied treatments such as Paclitaxel, Mirvetuximab Soravtansine, Carboplatin.
What is the best way to schedule an appointment with Katrina Wade, MD?
Apply for one of the trials that Katrina Wade, MD is conducting.
What is the office address of Katrina Wade, MD?
The office of Katrina Wade, MD is located at: Ochsner Medical Center Jefferson, New Orleans, Louisiana 70121 United States. This is the address for their practice at the Ochsner Medical Center Jefferson.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.